Skip to main content

US ClosedU.S. Closed

GLMD: Galmed Pharmaceuticals Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Galmed Pharmaceuticals Ltd. , a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases.

52W Range

14thpctl

Volume

3.81×avg

Market Cap

4.78MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Galmed Pharmaceuticals Ltd.

GLMDNASDAQ·USD·Closed

Galmed Pharmaceuticals Ltd.

GLMDNASDAQ·USD·Closed

$4.63

+21.05%

$4.63

+$0.80 (21.05%)

52W Range

14thpctl

Volume

3.81×avg

Mkt Cap

4.78MUSD

P/E

-0.3TTM

Div Yield

–ann